This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum salt adjuvant or its equivalent (such as aluminum hydroxide, aluminum phosphate, or calcium phosphate) and would benefit from the technology.

Author(s): PATH

Published: 2012

Resource types: PATH resource; Fact sheet

Diseases: Haemophilus influenzae type b (Hib); Hepatitis B; Japanese encephalitis; Malaria; Meningococcus; Pneumococcus; Shigellosis and enterotoxigenic Escherichia coli (ETEC); Rotavirus; Influenza; Respiratory syncytial virus (RSV); Polio

Topics: Cold chain logistics and technologies; Presentation and packaging; Vaccine stabilization

Regions: Global